Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02075112 · ClinicalTrials.gov registry record · Phase 1
Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck
A Phase 1 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT02075112 is a Phase 1 study that has completed, run by Emory University. The registered enrollment target is 24 participants.
The verdict
NCT02075112, a Phase 1 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if soy supplementation during chemotherapy and radiation therapy will decrease side effects caused by treatment. Long-lasting dry mouth is a side effect of the standard treatment, and we are testing whether soy supplementation during treatment may reduce this symptom and other side effects of chemoradiation.
Interventions
- DRUG Cisplatin
- RADIATION Radiation
- DRUG Soy isoflavone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-11 |
| Est. Completion | 2019-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02075112
The ClinicalTrials.gov registry entry for NCT02075112 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cisplatin is the first listed.
NCT02075112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02075112 about?
NCT02075112 is a clinical study titled "Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck". The purpose of this study is to determine if soy supplementation during chemotherapy and radiation therapy will decrease side effects caused by treatment. Long-lasting dry mouth is a side effect of the standard treatment, and we are testing whether soy supplementation during treatment may reduce thi...
What is the current status of trial NCT02075112?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2013-11. Estimated completion is 2019-09.
What interventions are being tested in trial NCT02075112?
The interventions under investigation include: Cisplatin (DRUG), Radiation (RADIATION), Soy isoflavone (DRUG).
Who is sponsoring clinical trial NCT02075112?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.